7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Cystatin C compared to serum creatinine as a marker of acute kidney injury in critically ill neonates

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Acute kidney injury (AKI) is one of the most common causes of neonatal morbidity and mortality. Diagnosing AKI in neonates is challenging as it lacks specific signs, symptoms, and biomarkers. However, detecting AKI in critically ill neonates is crucial to determine appropriate management and prevent complications. Cystatin C (CysC) has been recognized as a superior kidney biomarker reflecting kidney function in neonates. The objective of this study is to evaluate the diagnostic value of CysC as an AKI biomarker in critically ill neonates.

          Related collections

          Author and article information

          Contributors
          (View ORCID Profile)
          Journal
          Pediatric Nephrology
          Pediatr Nephrol
          Springer Science and Business Media LLC
          0931-041X
          1432-198X
          January 2021
          June 27 2020
          January 2021
          : 36
          : 1
          : 181-186
          Article
          10.1007/s00467-020-04668-3
          32594242
          884770fe-fc48-44ed-b6a5-b9265b144c31
          © 2021

          https://www.springer.com/tdm

          https://www.springer.com/tdm

          History

          Comments

          Comment on this article